150 related articles for article (PubMed ID: 34160081)
21. Injection of bevacizumab and cyanoacrylate glue for hereditary hemorrhagic telangiectasia.
Khoueir N; Borsik M; Camous D; Herman P; Verillaud B
Laryngoscope; 2019 Oct; 129(10):2210-2215. PubMed ID: 31566760
[TBL] [Abstract][Full Text] [Related]
22. The effects of epistaxis on health-related quality of life in patients with hereditary hemorrhagic telangiectasia.
Merlo CA; Yin LX; Hoag JB; Mitchell SE; Reh DD
Int Forum Allergy Rhinol; 2014 Nov; 4(11):921-5. PubMed ID: 25145809
[TBL] [Abstract][Full Text] [Related]
23. Outcome of septal dermoplasty in patients with hereditary hemorrhagic telangiectasia.
Fiorella ML; Ross D; Henderson KJ; White RI
Laryngoscope; 2005 Feb; 115(2):301-5. PubMed ID: 15689755
[TBL] [Abstract][Full Text] [Related]
24. Influence of temporary nasal occlusion (tNO) on epistaxis frequency in patients with hereditary hemorrhagic telangiectasia (HHT).
Wirsching KEC; Haubner F; Kühnel TS
Eur Arch Otorhinolaryngol; 2017 Apr; 274(4):1891-1896. PubMed ID: 28070641
[TBL] [Abstract][Full Text] [Related]
25. Hereditary hemorrhagic telangiectasia-laser treatment of epistaxis.
Poje G; Kavanagh MM
Ear Nose Throat J; 2017 Sep; 96(9):E10-E14. PubMed ID: 28931195
[TBL] [Abstract][Full Text] [Related]
26. Prospective pilot study of Floseal® for the treatment of anterior epistaxis in patients with hereditary hemorrhagic telangiectasia (HHT).
Lee JM; Wu V; Faughnan ME; Lasso A; Figol A; Kilty SJ
J Otolaryngol Head Neck Surg; 2019 Oct; 48(1):48. PubMed ID: 31615556
[TBL] [Abstract][Full Text] [Related]
27. TIMolol nasal spray as a treatment for epistaxis in hereditary hemorrhagic telangiectasia (HHT) - Study protocol of the prospective, randomized, double-blind, controlled cross-over TIM-HHT trial.
Andorfer KEC; Seebauer CT; Koller M; Zeman F; Berneburg M; Fischer R; Vielsmeier V; Bohr C; Kühnel TS
Clin Hemorheol Microcirc; 2022; 80(3):307-315. PubMed ID: 34864649
[TBL] [Abstract][Full Text] [Related]
28. Neodymium-YAG laser intranasal photocoagulation in hereditary hemorrhagic telangiectasia: an update report.
Kluger PB; Shapshay SM; Hybels RL; Bohigian RK
Laryngoscope; 1987 Dec; 97(12):1397-401. PubMed ID: 3683050
[TBL] [Abstract][Full Text] [Related]
29. New classification of nasal vasculature patterns in hereditary hemorrhagic telangiectasia.
Mahoney EJ; Shapshay SM
Am J Rhinol; 2006; 20(1):87-90. PubMed ID: 16539301
[TBL] [Abstract][Full Text] [Related]
30. The minimal important difference of the epistaxis severity score in hereditary hemorrhagic telangiectasia.
Yin LX; Reh DD; Hoag JB; Mitchell SE; Mathai SC; Robinson GM; Merlo CA
Laryngoscope; 2016 May; 126(5):1029-32. PubMed ID: 26393959
[TBL] [Abstract][Full Text] [Related]
31. Intranasal Efudix reduces epistaxis in hereditary hemorrhagic telangiectasia.
de Jel DVC; Disch FJM; Kroon S; Mager JJ; Verdam FJ
Angiogenesis; 2020 Aug; 23(3):271-274. PubMed ID: 32112177
[TBL] [Abstract][Full Text] [Related]
32. Validation of epistaxis severity score for hereditary hemorrhagic telangiectasia in Japan.
Hayama M; Maeda Y; Shikina T; Tatehara S; Inokuchi G; Hoag JB; Sato T; Obata S; Nakatani A; Amano Y; Hida E; Nibu KI; Inohara H
Auris Nasus Larynx; 2022 Jun; 49(3):415-420. PubMed ID: 34857410
[TBL] [Abstract][Full Text] [Related]
33. Management of epistaxis in hereditary haemorrhagic telangiectasia (HHT) patients using pulsed dye laser and the effect of withholding treatment during the COVID pandemic.
Jiang Y; Dennis SC; Brewin MP
Lasers Med Sci; 2022 Oct; 37(8):3147-3153. PubMed ID: 35635649
[TBL] [Abstract][Full Text] [Related]
34. Treatment of Hereditary Hemorrhagic Telangiectasia-Related Epistaxis.
Sautter NB; Smith TL
Otolaryngol Clin North Am; 2016 Jun; 49(3):639-54. PubMed ID: 27267016
[TBL] [Abstract][Full Text] [Related]
35. Management of epistaxis in hereditary hemorrhagic telangiectasia by Nd:YAG laser and quality of life assessment using the HR-QoL questionnaire.
Karapantzos I; Tsimpiris N; Goulis DG; Van Hoecke H; Van Cauwenberge P; Danielides V
Eur Arch Otorhinolaryngol; 2005 Oct; 262(10):830-3. PubMed ID: 15739086
[TBL] [Abstract][Full Text] [Related]
36. A new endoscopic staging system for hereditary hemorrhagic telangiectasia.
Reh DD; Yin LX; Laaeq K; Merlo CA
Int Forum Allergy Rhinol; 2014 Aug; 4(8):635-9. PubMed ID: 24782401
[TBL] [Abstract][Full Text] [Related]
37. Cauterization for epistaxis in hereditary hemorrhagic telangiectasia.
Dabiri J; Fakhoury R; Choufani G; Mine B; Hassid S
B-ENT; 2016; 12(1):9-16. PubMed ID: 27097388
[TBL] [Abstract][Full Text] [Related]
38. Pazopanib for severe bleeding and transfusion-dependent anemia in hereditary hemorrhagic telangiectasia.
Parambil JG; Gossage JR; McCrae KR; Woodard TD; Menon KVN; Timmerman KL; Pederson DP; Sprecher DL; Al-Samkari H
Angiogenesis; 2022 Feb; 25(1):87-97. PubMed ID: 34292451
[TBL] [Abstract][Full Text] [Related]
39. Clinical Practice Guideline: Nosebleed (Epistaxis).
Tunkel DE; Anne S; Payne SC; Ishman SL; Rosenfeld RM; Abramson PJ; Alikhaani JD; Benoit MM; Bercovitz RS; Brown MD; Chernobilsky B; Feldstein DA; Hackell JM; Holbrook EH; Holdsworth SM; Lin KW; Lind MM; Poetker DM; Riley CA; Schneider JS; Seidman MD; Vadlamudi V; Valdez TA; Nnacheta LC; Monjur TM
Otolaryngol Head Neck Surg; 2020 Jan; 162(1_suppl):S1-S38. PubMed ID: 31910111
[TBL] [Abstract][Full Text] [Related]
40. Endoscopic cryotherapy for the treatment of epistaxis due to hereditary hemorrhagic telangiectasia.
Kim JY; Oh JH; Kim GT; Kwon JH
J Craniofac Surg; 2014; 25(2):e120-2. PubMed ID: 24469376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]